Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140452 · ClinicalTrials.gov registry record · Phase 2
Phase II Study Using Thalidomide for the Treatment of ALS
A Phase 2 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00140452 is a Phase 2 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT00140452, a Phase 2 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The use of Thalidomide in patients with ALS who have disease progression.
Interventions
- DRUG Thalidomide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2005-02 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00140452
The ClinicalTrials.gov registry entry for NCT00140452 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Thalidomide is the first listed.
NCT00140452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00140452 about?
NCT00140452 is a clinical study titled "Phase II Study Using Thalidomide for the Treatment of ALS". The use of Thalidomide in patients with ALS who have disease progression.
What is the current status of trial NCT00140452?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2005-02. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00140452?
The interventions under investigation include: Thalidomide (DRUG).
Who is sponsoring clinical trial NCT00140452?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.